# Chiron Real Estate Inc. (XRN)

- Sector: Real Estate · Industry: Reit Healthcare Facilities
- SEC CIK: 0001533615 ([filings on EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001533615))
- Full page: https://inspectstocks.com/stocks/xrn
- Data as of: price 2026-09-28; newest filing used 2026-08-10; latest fiscal period ended 2026-06-30

## Grade

**A+** on the growth-and-cash rubric, 5 of 5 checks passed.

| Check | Result | Now | Before |
| --- | --- | --- | --- |
| Revenue growing overall | passed | $153.4M | $144.3M |
| Revenue growing recently | passed | $153.4M | $148.2M |
| Free cash flow positive | passed | $69.9M |  |
| Free cash flow growing overall | passed | $69.9M | -$74.4M |
| Free cash flow growing recently | passed | $69.9M | $3.1M |

Business quality (the + / − mark): 4 of 5 checks passed.

| Check | Result | Now | Before |
| --- | --- | --- | --- |
| Profitable | passed | 40.9% |  |
| Healthy profit margin | passed | 40.9% |  |
| Good return on equity | failed | 12.3% |  |
| Debt under control | passed | 0.03 |  |
| Turns sales into cash | passed | 45.5% |  |

How the grade works: the letter counts failed checks (none → A, one → B, two → C, three → D, four or more → F). It is built from SEC filings only — the share price never enters it — and describes the business, not whether the stock is worth buying.

## Key figures

In US dollars, as filed.

| Measure | Value |
| --- | --- |
| Revenue, trailing twelve months | $153.4M |
| Net income, trailing twelve months | $62.7M |
| Free cash flow, trailing twelve months | $69.9M |
| Net margin | 40.9% |
| Return on equity | 12.3% |
| Debt to equity | 0.03 |
| Diluted EPS, trailing twelve months | $3.89 |
| Share price | $35.42 |
| Market value | $468.9M |
| Price / earnings | 9.1x |
| Price / sales | 3.1x |

## More on this company

- [Overview](https://inspectstocks.com/stocks/xrn)
- [Financial statements](https://inspectstocks.com/stocks/xrn/financials)
- [Competitors](https://inspectstocks.com/stocks/xrn/peers)
- [Earnings](https://inspectstocks.com/stocks/xrn/earnings)

---

Source: InspectStocks, built from the company’s own SEC filings. This describes a business — it is not investment advice and not a recommendation to buy or sell anything.